TB-500 5mg. Used to support tissue repair, muscle recovery, joint and tendon health, and overall healing. Lab tested, discreetly shipped across Canada.
FormatLyophilized Vial
ConcentrationDependent on reconstitution with BAC water
Pack Size Selected: 5 Pack
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
TB-500 (Thymosin Beta-4 fragment) is a synthetic analogue of Thymosin Beta-4, a naturally occurring peptide involved in actin regulation and cell motility found in virtually all human and animal cells. iLab Pharma’s 5mg lyophilized vial delivers the lowest concentration single unit TB-500 presentation in CSD’s range, suited to researchers requiring precise low dose titration capability. Initiating dose response characterization studies at the lower end of the TB-500 concentration spectrum, or conducting shorter duration protocols where the 10mg single vial supply exceeds the compound volume required.
The 5mg concentration serves a distinct research purpose from the 10mg single vial and multi pack presentations within CSD’s TB-500 range. For dose response research examining TB-500’s actin mediated tissue repair activity across a defined concentration ladder, the 5mg format provides the lowest reference point, establishing sub threshold and near threshold activity levels before progressing through the 10mg single vial, 5 pack, and 10 pack supply options. For shorter duration protocols or research designs examining TB-500 activity at conservative dose points, the 5mg format provides a precisely matched compound volume without excess supply that would require extended refrigerated storage following reconstitution.
TB-500’s LKKTETQ actin binding domain mediates G actin sequestration and upregulation of actin polymerization dynamics, enhancing cellular migration to injury sites, supporting angiogenesis through a complementary mechanism to BPC-157’s nitric oxide pathway activity, and modulating inflammatory response in damaged tissue. This actin mediated mechanism’s well documented synergy with BPC-157’s FAK paxillin and growth factor receptor pathways has made TB-500 one of the most frequently co studied peptides in preclinical tissue repair research, and CSD’s comprehensive TB-500 range across multiple concentrations, supply volumes, and combination formats supports the full spectrum of standalone and co administration research protocols.
iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks TB-500 across single vials at 5mg and 10mg, multi packs at 50mg and 100mg total, and across five combination blend formats. Giving researchers complete concentration and supply volume flexibility from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.
Commonly researched alongside BPC-157 in tissue repair and recovery protocols. Browse CSD’s full peptide range for complete sourcing.
TB-500 is a synthetic research peptide associated with the biologically active LKKTETQ region of thymosin beta 4. This short peptide sequence is involved in actin related cellular processes and has been studied in connection with cell migration, angiogenesis, wound repair, and regenerative signaling. This product contains 5mg of lyophilized TB-500 in a single vial for laboratory research.
TB-500 is primarily associated with research into cell migration, angiogenesis, wound repair, connective tissue biology, and regenerative processes. Research involving thymosin beta 4 and its active regions has examined endothelial cell migration, blood vessel formation, tissue remodeling, inflammatory signaling, and recovery following tissue injury. Evidence for commercial TB-500 itself is more limited than the broader research on thymosin beta 4.
Thymosin beta 4 is a naturally occurring 43 amino acid peptide with important roles in actin regulation, cellular migration, and tissue repair. TB-500 is associated with the shorter acetylated LKKTETQ segment found within thymosin beta 4 rather than the complete native 43 amino acid molecule. The LKKTETQ region is particularly important to actin binding and several of the regenerative processes studied with thymosin beta 4.
The LKKTETQ-containing region of thymosin beta 4 has been linked experimentally to angiogenesis, wound healing, and cellular migration. These processes are central to tissue repair because endothelial and other cells must migrate into damaged areas while new blood vessels form to support regenerating tissue. Research on thymosin beta 4 has demonstrated effects on endothelial migration, vascular formation, and wound repair pathways.
Yes! This batch is HPLC tested to verify TB-500 identity and content accuracy at 5mg per vial. A certificate of analysis is available.
